Xaira

Nabla Bio

This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.

Metaphore Biotechnologies

This biotechnology company develops an artificial intelligence platform to design functional antibody medicines for pharmaceutical partners and patients with autoimmune, metabolic or oncology conditions.

Antiverse

This company uses generative AI to design functional antibody biologics for pharmaceutical organisations targeting complex medical conditions and transmembrane proteins.

Converge Bio

The company develops AI software for antibody design and optimization to assist pharmaceutical firms in drug discovery and development.

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

Absci

This biopharmaceutical company uses generative artificial intelligence to design and develop biologic medicines for pharmaceutical partners and clinical patients.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Drug Discovery

This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.